Course description

Course type


Course description

Ovarian stimulation remains an essential part of ART. Undoubtedly, there is a need to reliably predict ovarian response to stimulation, to tailor stimulation protocols, optimise the periovulatory hormonal environment, and thereby increase the probability of pregnancy while keeping the risks of complications and costs at a minimum.

In order to continue our educational and scientific activities, enforced by the COVID-19 travel restrictions, this virtual campus course will take place in two parts.

The first part ‘’Success in ART – Plan right’’, on January the 15th, will focus on how to optimally investigate, program and prime an IVF cycle.

The second part of the ‘’Success in ART – Treat right’’, on January the 22nd , will cover debated topics of ovarian stimulation protocols, embryo-transfer and luteal support of an IVF cycle.


Target audience

Reproductive medicine specialists and those in training, reproductive endocrinologists, gynaecologists, endocrinologists, embryologists, scientists interested in ART, nurses and midwives working in reproductive medicine


Expected educational outcomes

Participants having completed the course will be fully updated with evidence based knowledge on how to increase success rates in ART through optimisation of treatment protocols.
Participants will be able to incorporate this knowledge in clinical practice and in scientific and educational activities.


Innovative aspects of the course

World experts in the field of reproductive endocrinology will provide lectures and debates on topics of high interest in the field of reproductive endocrinology.
A view towards future perspectives of ART through stem cells will also be discussed during the Campus workshop.

Educational methods

  • Lectures
  • Discussions


The official language of the course is English. 

Certificate of attendance

Participants can obtain a certificate of attendance after completing the workshop evaluation. After the course, ESHRE will send an e-mail with the link and more information.